Clearside Biomedical rakes in $20 mln Series C
Alpharetta, Georgia-based Clearside Biomedical Inc, which focuses on treating blinding diseases of the eye, has closed $20 million in Series C funding. The investors included Aju IB Investment, Cormorant Asset Management, Perceptive Advisors and Rock Springs Capital Management. Trout Capital LLC advised Clearside on the transaction.
3 December 2015•2 mins read
